This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Children's Medical Center Corporation, The Schepens Eye Research Institute, Inc., The United States Government as Represented by the Department of Veterans Affairs. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,076 
2 out of 133 
1 out of 961 
Years Active: 2017-2021
Title: The Innovative Contributions of Paraskevi Evi Kolovou
Introduction
Paraskevi Evi Kolovou is a notable inventor based in Boston, MA (US). She has made significant contributions to the field of ocular medicine, particularly through her innovative patents. With a total of 2 patents, her work focuses on advancing treatments for ocular diseases.
Latest Patents
Kolovou's latest patents revolve around the use of ABCB5(+) stem cells for treating ocular diseases. These patents detail various methods for treating subjects with ocular conditions, isolating ocular stem cells, and producing ocular grafts for transplantation. Additionally, her inventions promote ocular cell regeneration and include grafts and preparations containing isolated ocular stem cells characterized by the expression of ABCB5 on their cell surface.
Career Highlights
Throughout her career, Kolovou has worked with esteemed organizations such as the Schepens Eye Research Institute and Children's Medical Center Corporation. Her experience in these institutions has allowed her to collaborate with leading experts in the field, enhancing her research and innovation capabilities.
Collaborations
Some of her notable coworkers include Markus H. Frank and Natasha Y. Frank, who have contributed to her research endeavors. Their collaboration has furthered the understanding and treatment of ocular conditions.
Conclusion
Paraskevi Evi Kolovou's contributions to ocular medicine through her patents and collaborations highlight her dedication to innovation in the field. Her work continues to pave the way for advancements in treating ocular diseases, showcasing the impact of her research on improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile